Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.96 HKD | +1.02% | +1.53% | -10.78% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 08 | Ocumension Therapeutics' Eye Drug Completes Clinical Trials, to Apply for NDA Soon | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 1477 Stock
- Revisions Ocumension Therapeutics